These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21249164)

  • 21. Activators of α7 nAChR as Potential Therapeutics for Cognitive Impairment.
    Wang X; Bell IM; Uslaner JM
    Curr Top Behav Neurosci; 2020; 45():209-245. PubMed ID: 32451955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tropisetron and its targets in Alzheimer's disease.
    Hashimoto K
    Expert Opin Ther Targets; 2015 Jan; 19(1):1-5. PubMed ID: 25399811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression levels of the α7 nicotinic acetylcholine receptor in the brains of patients with Alzheimer's disease and their effect on synaptic proteins in SH-SY5Y cells.
    Ren JM; Zhang SL; Wang XL; Guan ZZ; Qi XL
    Mol Med Rep; 2020 Sep; 22(3):2063-2075. PubMed ID: 32582986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.
    Oz M; Lorke DE; Yang KH; Petroianu G
    Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.
    Young JW; Geyer MA
    Biochem Pharmacol; 2013 Oct; 86(8):1122-32. PubMed ID: 23856289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.
    Lewis AS; van Schalkwyk GI; Bloch MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():45-53. PubMed ID: 28065843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q; Xie X; Emadi S; Sierks MR; Wu J
    Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease.
    Matsuura Y; Ueda M; Higaki Y; Sano K; Saji H; Enomoto S
    Mol Imaging Biol; 2019 Jun; 21(3):519-528. PubMed ID: 30047036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials.
    Russo P; Del Bufalo A; Frustaci A; Fini M; Cesario A
    Curr Pharm Des; 2014; 20(38):6014-21. PubMed ID: 24641224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
    Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
    PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid β-protein suppressed nicotinic acetylcholine receptor-mediated currents in acutely isolated rat hippocampal CA1 pyramidal neurons.
    He YX; Wu MN; Zhang H; Qi JS
    Synapse; 2013 Jan; 67(1):11-20. PubMed ID: 23015319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology.
    Thomsen MS; Hansen HH; Timmerman DB; Mikkelsen JD
    Curr Pharm Des; 2010 Jan; 16(3):323-43. PubMed ID: 20109142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway.
    Wang XL; Deng YX; Gao YM; Dong YT; Wang F; Guan ZZ; Hong W; Qi XL
    Aging (Albany NY); 2020 Jan; 12(1):543-570. PubMed ID: 31905173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippocampal network dynamics in response to α7 nACh receptors activation in amyloid-β overproducing transgenic mice.
    Stoiljkovic M; Kelley C; Hajós GP; Nagy D; Koenig G; Leventhal L; Hajós M
    Neurobiol Aging; 2016 Sep; 45():161-168. PubMed ID: 27459936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated administration of alpha7 nicotinic acetylcholine receptor (nAChR) agonists, but not positive allosteric modulators, increases alpha7 nAChR levels in the brain.
    Christensen DZ; Mikkelsen JD; Hansen HH; Thomsen MS
    J Neurochem; 2010 Aug; 114(4):1205-16. PubMed ID: 20533993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia.
    Hajós M; Rogers BN
    Curr Pharm Des; 2010; 16(5):538-54. PubMed ID: 19909231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711.
    Hashimoto K; Ishima T; Fujita Y; Matsuo M; Kobashi T; Takahagi M; Tsukada H; Iyo M
    Biol Psychiatry; 2008 Jan; 63(1):92-7. PubMed ID: 17601496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
    Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
    Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.